AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Novonesis AS

Transaction in Own Shares Feb 17, 2012

3377_dirs_2012-02-17_f6ca5b61-8c18-4950-adc5-dd59ccd38b17.pdf

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

February 17, 2012

On January 20, 2012, Novozymes initiated a share buyback program in accordance with the provisions of European Commission Regulation no. 2273/2003 of December 22, 2003, also referred to as the Safe Harbour Regulation.

Under the program Novozymes will buy back B shares for an amount of up to DKK 1,000 million in the period from January 20, 2012, to December 31, 2011.

The following transactions have been made under the program:

Number of shares Average purchase price Transaction value, DKK
Accumulated, last announcement 531,845 85,169,443
February 10, 2012 18,000 163.46 2,942,295
February 13, 2012 18,000 163.93 2,950,703
February 14, 2012 35,000 163.29 5,715,178
February 15, 2012 17,441 166.10 2,896,924
February 16, 2012 37,539 166.63 6,255,140
Accumulated under the program 657,825 105,929,683

Transactions related to Novozymes' incentive programs have resulted in a net sale by Novozymes of 122,321 B shares in the period from February 10, to February 16, 2012. The shares related to these transactions were not part of the Safe Harbour share buyback program.

With the transactions stated above, Novozymes owns a total of 9,197,110 treasury shares, corresponding to 2.8% of the share capital. The total amount of shares in the company is 325,000,000 including treasury shares.

Contact persons: Press and media: Investor relations: René Tronborg (Europe) Tel. (direct): +45 4446 2274 Tel. (mobile): +45 3077 2274

Paige Donnelly (USA) Tel. (direct): +1 919 494 3209 Tel. (mobile): +1 919 218 4501 Martin Riise Tel. (direct): +45 4446 0738 Tel. (mobile): +45 3077 0738

Thomas Bomhoff (USA) Tel. (direct): +1 919 494 3483 Tel. (mobile): +1 919 649 2565

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.

Telephone: +45 4446 0000 Fax: +45 4446 9999 Internet: www.novozymes.com CVR number: 10 00 71 27

Talk to a Data Expert

Have a question? We'll get back to you promptly.